1. FDA. FDA’s decision to approve new treatment for Alzheimer’s disease. 2021. www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease.
2. FDA considers Alzheimer’s drug previously abandoned for lack of effectiveness
3. FDA. Final summary minutes of the Peripheral and Central Nervous System Drugs Advisory Committee meeting. 6 November 2020. www.fda.gov/advisory-committees/advisory-committee-calendar/november-6-2020-meeting-peripheral-and-central-nervous-system-drugs-advisory-committee-meeting.